Skip to content
Home / Companies / GMED GME
GLOBUS MEDICAL INC (GMED) XNYS SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Net insider selling (90d)
Latest GMED Insider Trades
About GLOBUS MEDICAL INC (GMED) Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Headquarters AUDUBON, PA
Employees 6,000
Listed 2012
Exchange XNYS https://www.globusmedical.com SEC filings for GMED on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 2 50,000 $4.20M Option exercise 6 150,000 Bona-fide gift 1 2,500
GMED Insider Transactions (Form 4) 57 41 Form 4 filings on record, the earliest from Oct 18, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 18, 2026 SZ Stephen T. Zarrilli - Director Option exercise Class A Common Stock 25,000
Recent GMED Form 8-K Filings 5
Recent GMED Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 18, 2026 ZARRILLI STEPHEN T Director 25,000 $2.18M View on EDGAR Jun 5, 2026 - -
GMED Insider Trading - FAQ
What is the latest insider trade for GMED? GLOBUS MEDICAL INC (GMED) had 4 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for GMED runs to 41 Form 4 filings, the earliest from 2024-10-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying GMED stock? No insider purchases of GMED were filed in the last 90 days.
How many insiders are selling GMED stock? 2 insider sales of GMED were filed in the last 90 days, totaling $4.20M.
Where can I see GMED SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks GMED Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow GMED insider buys? Create a free InsiderAlpha account and press Watch on this page to add GMED to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track GMED insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free KK Kyle Kline - Officer Open-market sale $363K
Jan 8, 2026
KK Kyle Kline - Officer Open-market sale $1.67M
Dec 1, 2025
Market cap $11.14B
P/E ratio 110.60
Dividend yield -
Average volume 1.63M
52 week high $101.40
52 week low $54.15
Today's high $83.53
Today's low $81.80
Open $82.61
Volume 1.06M
Previous close $82.54
Shares outstanding 134.26M Market cap
$11.14B
6,000 employees
GMED Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 2 sales totaling $4.20M.
Most-Active GMED Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 18, 2026 SZ Stephen T. Zarrilli - Director Open-market sale Class A Common Stock 25,000 $87.04 $2.18M
Aug 18, 2026 SZ Stephen T. Zarrilli - Director Option exercise Stock Option (Right to Buy Class A Common Stock) 25,000 $0.00 -
Jun 5, 2026 DD David D. Davidar Option exercise Class A Common Stock 25,000 $26.27 $657K
Jun 5, 2026 DD David D. Davidar Open-market sale Class A Common Stock 25,000 $80.76 $2.02M
Jun 5, 2026 DD David D. Davidar Option exercise Stock Option (Right to Buy Class A Common Stock) 25,000 $0.00 -
Jun 4, 2026 AR Ann D. Rhoads Option exercise Class A Common Stock 25,000 $26.27 $657K
Jun 4, 2026 AR Ann D. Rhoads Option exercise Stock Option (Right to Buy Class A Common Stock) 25,000 $0.00 -
Feb 25, 2026 KH Kelly Huller - Officer Option exercise Class A Common Stock 20,000 $43.58 $872K
Feb 25, 2026 KH Kelly Huller - Officer Open-market sale Class A Common Stock 20,000 $94.50 $1.89M
Feb 25, 2026 KH Kelly Huller - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 20,000 $0.00 -
Feb 12, 2026 KH Kelly Huller - Officer Option exercise Class A Common Stock 10,000 $45.64 $456K
Feb 12, 2026 KH Kelly Huller - Officer Open-market sale Class A Common Stock 10,000 $87.67 $877K
Feb 12, 2026 KH Kelly Huller - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 10,000 $0.00 -
Jan 21, 2026 LN Leslie V. Norwalk Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 KP Keith W. Pfeil - Officer Grant or award Stock Option (Right to Buy Class A Common Stock) 100,000 $0.00 -
Jan 21, 2026 KK Kyle Kline - Officer Grant or award Stock Option (Right to Buy Class A Common Stock) 30,000 $0.00 -
Jan 21, 2026 DP David C. Paul - Officer Grant or award Stock Option (Right to Buy Class A Common Stock) 100,000 $0.00 -
Jan 21, 2026 RD Robert Andrew Douglas Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 DL Dan Lemaitre Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 AR Ann D. Rhoads Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 SZ Stephen T. Zarrilli Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 JD John A. Deford Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 DW Dan Wolterman Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 DD David D. Davidar Grant or award Stock Option (Right to Buy Class A Common Stock) 15,000 $0.00 -
Jan 21, 2026 KH Kelly Huller - Officer Grant or award Stock Option (Right to Buy Class A Common Stock) 40,000 $0.00 -
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 4,896 $0.00 -
Jan 8, 2026 KK Kyle Kline - Officer Option exercise Class A Common Stock 3,594 $51.87 $186K
Jan 8, 2026 KK Kyle Kline - Officer Open-market sale Class A Common Stock 3,594 $101.10 $363K
Jan 8, 2026 KK Kyle Kline - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 3,594 $0.00 -
Dec 8, 2025 DP David C. Paul - Officer Option exercise Class A Common Stock 34,375 $25.52 $877K
Dec 8, 2025 DP David C. Paul - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 34,375 $0.00 -
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Class A Common Stock 3,646 $53.14 $194K
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Class A Common Stock 5,000 $56.43 $282K
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Class A Common Stock 5,000 $64.44 $322K
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Class A Common Stock 4,896 $63.68 $312K
Dec 1, 2025 KK Kyle Kline - Officer Open-market sale Class A Common Stock 18,542 $90.00 $1.67M
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 3,646 $0.00 -
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 5,000 $0.00 -
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 5,000 $0.00 -
Dec 1, 2025 KK Kyle Kline - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 5,000 $0.00 -
Nov 25, 2025 KH Kelly Huller - Officer Option exercise Class A Common Stock 7,500 $25.96 $195K
Nov 25, 2025 KH Kelly Huller - Officer Open-market sale Class A Common Stock 7,500 $90.00 $675K
Nov 25, 2025 KH Kelly Huller - Officer Option exercise Stock Option (Right to Buy Class A Common Stock) 7,500 $0.00 -
Nov 12, 2025 DD David D. Davidar Option exercise Class A Common Stock 25,000 $25.52 $638K
Nov 12, 2025 DD David D. Davidar Open-market sale Class A Common Stock 25,000 $86.00 $2.15M
Nov 12, 2025 DD David D. Davidar Option exercise Stock Option (Right to Buy Class A Common Stock) 25,000 $0.00 -
Nov 11, 2025 SZ Stephen T. Zarrilli Option exercise Stock Option (Right to Buy Class A Common Stock) 25,000 $0.00 -
Nov 7, 2025 AR Ann D. Rhoads Open-market sale Class A Common Stock 8,000 $81.00 $648K
Nov 10, 2025 AR Ann D. Rhoads Open-market sale Class A Common Stock 2,000 $85.00 $170K
Sep 15, 2025 AR Ann D. Rhoads Open-market sale Class A Common Stock 10,000 $58.46 $585K
$GRI
GRI Bio, Inc.
$OBIO
Orchestra BioMed Holdings, Inc.
